INTRODUCTION
The clinical implementation of whole genome array comparative genomic hybridization (array-CGH) has revolutionised the diagnosis of patients with mental retardation, congenital anomalies or neuropsychiatric disorders. With high-density microarrays, presence of chromosome imbalances is detected in up to 17 of idiopathic developmental delay-mental retardation. On the basis of array-CGH data, lead to the identification of several genes involved in monogenic disorders, such as in CHARGE and in Recently, Cardoso reported 3 cases of 5q14.3-q15 deletions presenting with severe mental retardation, hypotonia, seizures, et al 8 minor dysmorphic features and periventricular heterotopia and an additional case has been reported in the Decipher database (https://decipher.sanger.ac.uk/application/). Here, we report the detection of five distinct 5q14 deletions in 5 unrelated patients presenting with severe mental retardation, absent speech and stereotypic movements and one duplication of the 5q14 region in a patient with mental retardation. These deletions, which are different to those reported by Cardoso et al , allowed us to define a minimal critical region 8 encompassing only the gene and led us to sequence this gene in patients with similar phenotypes. We provide arguments MEF2C indicating that this severe mental retardation results from haploinsufficiency. MEF2C
PATIENTS AND METHODS

Patients
All 7 patients included in this study have been examined by a clinical geneticist in the context of etiologic investigations in children affected with developmental delay. Array-CGH analysis was performed since mental retardation was associated with at least two of the following criteria, dysmorphic facial features, family history of mental retardation, growth anomaly or congenital malformation. For i.e. the 7 patients, high resolution chromosome analysis and extensive biochemical metabolic screening (lactic acid, pyruvic acid, ammoniac, plasmatic amino acids and urine organic acids analyses, purine metabolism, blood and urinary creatine and guanido-acetic acid) were normal. For each patient, blood samples for genetic analyses were collected after having obtained written informed consent of the parents.
Clinical presentations of the patients are summarized in . Table 1 Case 1 BV is the third child of healthy unrelated parents. She was born at 36 week s gestation (WG) with normal growth parameters. At 3 ' days of age, she experienced a single episode of cyanosis with eye revulsion. Frequent crying, sleep disturbance, hypotonia and poor visual contact were noted at 3 months. From the age of 4 months, myoclonic jerks of the upper limbs were noted and followed, several weeks later, by brief episodes of eye revulsion concomitant with the jerks. Epilepsy was diagnosed at the age of 7 months and characterized by the association of several bilateral isolated spasms and frequent synchronous myoclonus with abnormal and slow background EEG pattern.
Clinical examination at 4 years 9 months showed normal growth and head circumference. Developmental delay was severe. She sat unaided and was able to crawl manipulate toys. Eye contact was present though transient. Speech was absent. She had stereotypic repetitive movements, rocking her head and rubbing her chin with her hands. Subtelomeric rearrangements were excluded by QMPSF (Quantitative Multiplex PCR of Short Fluorescent Fragments). Analysis of the gene revealed no alteration. CDKL5
Case 2
CA is the second child of healthy unrelated parents. At birth, at 40 WG, weight and length were normal but head circumference was along the 3 standard deviation (SD). Since the first day of life, she developed tonico-clonic seizures. EEG revealed frequent bursts with − no basic rhythm and a very unstructured pattern. At 9 months of age, severe hypotonia and poor eye contact were noted. Awakening stages were short. Despite treatment, the seizures occurred every day.
Case 3
ED is the second child of healthy unrelated parents. Delivery was provoked at 41 WG because of abnormal foetal cardiac rhythm. A birth, weight and length were on 3 SD but head circumference was small ( 2.5 SD). At the age of 2 months, severe hypotonia and absent LD is the second child of healthy parents who were first cousins. She was born at 40WG, with growth parameters below 2SD. − Hypotonia and developmental delay were observed during the first months of life. At 3 years of age, she experienced tonico-clonic febrile seizures which were well controlled by valproate. At 7 years, she was unable to walk and had not acquired any language skill. She had repetitive hand washing and hand-to-mouth movements as well as frequent bouts of hyperventilation. Subtelomeric rearrangements were excluded by FISH. Screening of the gene revealed no deleterious mutation. MECP2
Case 6
TM is the third child of healthy unrelated parents. Growth parameters at birth on term were in the normal range. He was first referred at the age of 2 years 6 months for a mild global developmental delay. He was able to walk unaided since the age of 2 years. Cerebral MRI and EEG were normal. Clinical examination at 6 years of age revealed a microcephaly ( 3 SD) with normal height and weight. He − presented mental retardation: IQ was evaluated between 50 and 60 (WISC IV). Speech was severely delayed but understandable; he was not able to pronounce short sentences. Eye contact, behaviour, and social skills were normal. Special education was required. Subtelomeric rearrangements and the most frequent microdeletion syndromes were excluded using the MLPA (Multiplex Ligation-dependent Probe Amplification) method.
Case 7
DG is the first girl born to healthy non-consanguineous parents with an unremarkable family history. She was born on term after an uneventful pregnancy. At birth, growth parameters were normal. The neonatal period was normal apart from difficulties in breastfeeding.
She appeared to develop normally until the age of 5 months. From the age of 5 months, she started to regress and to lose previously acquired skills. She was unable to use her hands purposefully and failed to acquire vocalization with intonation. She walked unaided at age 3 years. She presented behavioral disorders, including decreased eye contact, lack of emotional reciprocity, lack of interest in her surroundings and hand and hand-mouth stereotypic movements. She also had severe feeding difficulties that started at age 5 months and were still present at 7 years of age. Generalized tonico-clonic seizures, well controlled on sodium valproate, started at age 9 months. At 7 years of age, she was severely mentally impaired and presented with poor eye contact and no speech. Neurological examination showed an unstable, wide-based gait, without any objective cerebellar signs. Sequencing of the and genes revealed no mutation. MECP2 CDKL5
Standard and molecular karyotyping
Karyotyping of RHG-banded chromosomes from lymphocytes at 550-band resolution was performed according to standard procedures. High molecular weight genomic DNA was extracted from patient s peripheral blood lymphocytes using the QIAamp DNA ' Blood Midi kit (Qiagen, Valencia, CA, USA) according to the manufacturer s instructions. DNA concentration was determined with ' NanoDrop ND-1000 spectrophotometer and software (NanoDrop Technologies, Berlin, Germany). Detection of gene copy number was performed by array-CGH following standard and manufacturer s recommendations (Agilent, Agilent Technologies, Santa Clara, CA, ' USA) using 44 000 oligo probes approximately spaced at 35 40 kb intervals across the genome (Human Genome CGH microarray 44B kit, Agilent) or 244 000 oligo probes approximately spaced at 10 kb intervals across the genome (Human Genome CGH microarray 244B kit, Agilent). Commercial (Promega, Madison, WI, USA) or non commercial female and male genomic DNA were used as references.
Hybridization results were extracted with Feature extraction software and analyzed with the DNA-analytics software by applying a Z-score or ADM 2 segmentation algorithm to identify chromosome aberrations. Copy-number gains and losses were determined by threshold of 0.3 and 0.3, respectively. Aberrant signals obtained with three or more neighbouring oligonucleotides were considered indicative of − genomic aberrations and further evaluated by FISH, MP-LC, qPCR and/or QMPSF, unless they coincided with a published DNA copy-number variant, as listed in the Database of Genomic Variants ( , version June 2008). http://projects.tcag.ca/variation/?source=hg18
FISH analysis
Aberrations were validated by Fluorescence hybridization (FISH) experiments (see supplementary data). FISH was performed in situ with RP11-1006G2 (case 1), with RP11-1147F22 (case 2 and case 3), with CTD-2328P23, RP11-1147F22 and RP11-110I3 (case 5) and with CTD-2328P23 (case 6).
QMPSF (Quantitative Multiplex PCR of Short Fluorescent Fragments)
exon 2 was PCR-amplified using the dye-labeled primers MEF2C-F (5 MEF2C ′ -CGTTAGATAGTGGGAACTGAGCTGTGCAAGT-3 ) and MEF2C-R (5 -GATAGGGTTACGTTCATCCATAATCCTCGTAATC-3) .
′ ′ '
Exon 13 of located on chromosome 11 and exon 4 of located on chromosome Xq28, were co-amplified as controls, using HMBS MECP2
the dye-labeled primers HMBS-F (5 -CGTTAGATAGACGGCTCAGATAGCATACAAG-3 ); and HMBS-R (5 intron 2 was PCR-amplified using the following primers: MEF2C-MPLC-F (5 -TAATCCAGGAGCCACAGGTC-3 ) and MEF2C 
Quantitative PCR
Quantitative PCR (qPCR) of was performed using SYBR green (see supplementary data). The gene, was used for MEF2C RPPH1
normalisation. MEF2C exon 1 was amplified with the primer MEF2C-E1-F (5 -TGTCAGGGTTTGGACAACAA-3 ) and MEF2C-E1-R (5 ′ ′ -TGGCAATTGAAACTCACCA-3 ) and exon 2 was amplified with MEF2C-E2-F (5 -CACATTTGAAGGTGCCAAAG-3 ) and
Sequencing analysis of the gene MEF2C
The 10 coding exons of the gene, including the exon-intron junctions, were PCR-amplified (primers are available on request) MEF2C from 100 ng of genomic DNA in 50 l containing 1.5 mM MgCb, 75 mM Tris-HCl (pH 9 at 25 C), 20 mM (NH4) SO , 0.01 Tween 20, 
RESULTS
In the course of systematic molecular karyotyping of patients with syndromic mental retardation, we identified five 5q14 deletions and one 5q14 duplication. All patients with 5q14 deletion (cases 1 to 5, ) presented with early and severe developmental delay and Table 1 hypotonia. Speech was absent in all cases. None of the children was able to walk unaided. Stereotypic movements were present in 3/5 patients and absent in the two youngest children. Different types of epilepsy were observed in 3/5 of our patients, from well controlled generalized seizures to early refractory tonicoclonic or myoclonic epilepsy. Miscellaneous dysmorphic facial features were present in all cases ( ), but some common features were noticed high and wide forehead, pronounced eyebrows, anteverted nostrils, short and fig. 1 i.e. prominent philtrum, down turned corners of the mouth and small chin. In 3/5 cases, palpebral fissures were up-slanted.
All patients with 5q14 deletion displayed MRI abnormalities ( ), including either corpus callosum agenesis (2/5) or increased table 1 corpus callosum thickness and shortness (1/5), abnormal gyration (1/5), fronto-parietal atrophy and enlarged pericerebral spaces (1/5), enlarged lateral ventricle (2/5) or enlarged fourth ventricle (2/5). As shown in and , the 5q14 deletions measured approximately figures 2 3 2.68 Mb (case 1), 3.5 Mb (case 2), 8.8 Mb (case 3), 1.57 Mb (case 4) and 216 Kb (case 5). In case 6, we detected a 5q14 duplication which size was estimated to 4.6 Mb. These 5q14 rearrangements were all confirmed by a second independent method, i.e. QMPSF (case 1), MP-LC (case 5 and 6), qPCR (case 4) and/or FISH analysis (case 1, 2, 3, 5 and 6) and segregation analyses revealed that they all had occurred ( ). The smallest rearrangement detected in case 5, presenting a Rett-like phenotype with developmental delay, poor de novo fig. 4 eye contact, epilepsy, stereotypic hand-mouth movements, episodes of hyperventilation and apnea, corresponded to a 216 Kb deletion which encompassed a single gene, restricting therefore the minimal common deleted region to this gene. MEF2C, In cases 1, 2, 3 and 5, the deletion removed entirely the gene. In case 4, q-PCR showed a partial deletion of removing MEF2C MEF2C the first exon, the breakpoint being located within intron 1. These observations led us to perform sequencing analysis of the gene MEF2C in 5 additional patients affected with severe mental retardation, in whom the diagnosis of the Rett phenotype had been suggested and for whom the array CGH array was normal. As shown in , in one patient (case 7), we identified a point mutation within exon 7 fig. 4C (NM_002397.2:c.683C>G) predicted to result in a premature stop codon (p.Ser228X). Sequencing analysis performed in the parents revealed that the mutation had occurred de novo.
DISCUSSION
We here report on five 5q14 submicroscopic deletions, one 5q14 duplication and one nonsense mutation in 7 unrelated MEF2C children, all presenting with mental retardation.
The clinical significance of the 5q14.3 duplication remains uncertain and, despite its occurrence, it may represent a benign de novo variant. Such non-pathogenic duplications have been described, contrasting with the deleterious deletion mirror event. Alternatively, the 8 5q14.3 duplication may be responsible for a mild phenotype distinct from that resulting from the deletions. Indeed, 7q11.23, 16p 13.11 and 17p11.2 duplications result into relatively mild phenotype compared to deletions. Study of additional patients will be required to 9 -11 determine the pathogenic effect of the 5q14.3 duplication. In the five cases with 5q14.3 microdeletion, the developmental delay was severe, associating hypotonia, poor eye contact and stereotypic hand movements (3/5). Moreover, in cases 4 and 5, classical Rett syndrome had initially been suspected because of repetitive clapping hand-mouth movements. However, these two latter patients did not display any period of normal development or a progressive loss of motor or communicative skills. Epilepsy was present in 3 cases. In one case, refractory myoclonic epilepsy with atypical spasms beginning before 6 months of age, led us to consider initially the hypothesis of an early-onset seizures variant of Rett syndrome due to mutation. Nevertheless, the presence of dysmorphic facial features in all five cases was strongly suggestive of a chromosomal CDKL5 aberration.
Only few interstitial 5q14 deletions detected by standard chromosomal analysis had previously been reported and were shown 12 -18 to be associated with severe to moderate mental retardation, growth retardation, deep hypotonia, facial dysmorphism and malformations.
The facial features included prominent forehead, epicanthal folds, brachycephaly, hypertelorism, flat nasal bridge, anteverted nostrils, abnormal ears and short neck. Malformations were miscellaneous and included renal abnormalities, cleft palate, club feet, heart defect, and dislocated hips. Among these cases, a clinical phenotype could hardly be delineated and epilepsy had not previously been reported.
Boundaries of the deletions in the different published cases are hardly comparable because of the low resolution level of chromosome analyses.
The three 5q14.3-q15 deletion cases, recently reported by Cardoso , and an additional case reported in the Decipher database et al 8 partially overlap with the 5q14.3 deletions that we report here. The critical regions, defined by the latter cases, are different. The common clinical features presented both by these 4 previously described patients and the 5 cases described here include mental retardation, seizures and dysmorphic facial features. Nevertheless, in contrast to the patients described by Cardoso , none of our cases presented et al 8 periventricular heterotopia. However, in our patients, a developmental defect of the neuronal migration with ectopic neurons cannot not be formally excluded as a cause of the severe and early epilepsy associated with mental retardation.
In our patients, the 5q14 deletion sizes ranged from 216 Kb to 8.8 Mb. The absence of low copy repeat (LCR) sequences flanking the breakpoints as well as the absence of recurrent breakpoints suggested that these rearrangements did not result from non-allelic homologous recombination and involve another mechanism such as non homologous end joining of DNA breaks. The detection of a 216 Kb deletion, removing only the gene, is a first argument supporting that haploinsufficiency of this gene contributes to the 5q14 microdeletion MEF2C syndrome.
deletion is not a common CNV ( ) and the origin of the 5 MEF2C http://projects.tcag.ca/variation/?source=hg18 de novo deletions reported in this study is in agreement with their causal role in the patient phenotypes. Although we cannot formally exclude that haploinsufficiency of other 5q14 genes contribute to the phenotype of patients harbouring larger deletions, the fact that the 5 patients reported in this study and presenting different deletion sizes showed striking phenotypic similarities ( ) strongly suggests that the Table 1 phenotype is mainly due to deletion. Finally, the identification of an inactivation point mutation within gene in case 7 MEF2C MEF2C constitutes a key argument demonstrating that haploinsufficiency of this gene results in mental retardation. The causal role of MEF2C alteration in the phenotype observed is in agreement with the biological function of the MEF2C protein and the murine models of MEF2C inactivation. Indeed, Myocyte Enhancer Factor 2 (MEF2) transcription factors act, in the brain, as effectors of neurogenesis which regulate excitatory synapse number, dendrite morphogenesis and differentiation of post synaptic structures . The role of MEF2 proteins in 19 20 synaptic plasticity is consistent with a role in learning and memory. MEF2C is the predominant isoform in the developing cerebrocortex and is highly expressed in frontal cortex, entorhinal cortex, cerebellum, dentate gyrus and amygdale.
Conditional -null mice 21 -22 Mef2c were generated as the knockout of the gene is embryonic lethal. , Late embryonic deletion of in the forebrain causes Mef2c 23 24 Mef2c hippocampus-dependent learning and memory impairment associated to a dramatic increase in the number of excitatory synapses. The 24 role of Mef2c in synaptic plasticity in mice, limiting the excessive increase in the number of excitatory, is consistent with its possible implication in seizures in human. In mutant mice with earlier embryonic deletion, abnormal aggregation and compaction of neurons migrating into the lower layers of the neocortex during development were observed. As a consequence, the cortical plate in 23 postnatal/adult neocortex in these conditional -null mice displays disorganization and the neurons exhibit immature Mef2c electrophysiological properties characteristic of an immature neuronal network. These murine phenotypes provide convincing arguments for the implication of haploinsufficiency as the cause of mental retardation observed in all cases and epilepsy in 4 of our cases. MEF2C Furthermore, the role of MEF2C in neuronal migration is of particular interest regarding to the periventricular heterotopia described by In conclusion, our results indicate that haploinsufficiency caused either by 5q14.3 microdeletion or by mutation is responsible MEF2C for a severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
Figure 1
Frontal and profile views of the 5 patients carrying 5q14 microdeletion or mutation. Note high and wide forehead, thick eyebrows, MEF2C short nose with anteverted nostrils, short and prominent philtrum, down turned corners of the mouth and small chin. (A) Case 1, note " question mark ears (constriction at the junction between the lower and the middle thirds of the pinna); (B) Case 2; (C) Case 3; (D) Case 4; (E) " Case 5; (F) Case 7 harbouring the mutation. MEF2C
Figure 2
Array-CGH profiles on chromosome 5 using Agilent 44K or 244K microarray (DNA analytics solftware display) showing the five microdeletions and the microduplication. In case 1, 244K microarray shows that the proximal and distal breakpoint of the deletion are respectively located between 86,939,816 and 87,005,072 and between 89,690,632 and 89,709,694. Using 44K microarrays, the proximal breakpoints of the four other deletions and of the duplication were located between 87,770,283 and 88,051,970 in case 2, between 86,142,271 and 86,412,812 in case 3, between 88,185,407 and 88,268,343 in case 4, between 87,770,283 and 88,051,970 in case 5 and between 85,951,601 and 86,142,512 in case 6. Note that in patient 4, the proximal breakpoint has been localized by qPCR, between 88,221,326 and 88,235,476. The distal breakpoints of these rearrangements are respectively located between 91,578,247 and 91,730,827 in case 2, between 95,315,261 and 95,494,937 in case 3, between 89843194 and 89966438 in case 4, between 88,268.402 and 88,629.033 in case 5 and between 90,712,814 and 90,731,163 in case 6. The Human Gene Assembly used to define the extensions of the deletion is Hg18.
Figure 3
Schematic representation of the 5q14 genomic region. gene is indicated by black box. BAC clones appear above the genomic MEF2C representation and black bars. The minimal extents of deletions and of the duplication are respectively shown by grey boxes and a black box below the chromosome scheme. The maximal extents of the region implicated are shown by dotted lines. Note that the smallest CNV detected is a deletion of a single gene, , located from approximately 88,051,970 to 88,268,402 in hg 18 (in patient 5). MEF2C
Figure 4
Confirmation of the 5q14 deletion by QMPSF and FISH in case 1. (A) Electropherogram in case 1 (in red) was superimposed to that of a normal female (in blue) by adjusting to the same level the peaks obtained for the and control amplicons. Case 1 is a female. 
